Julia Kazakin
Impact in
Papers in
- Surgery 10
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
-
- Fibroblast Growth Factor Research 6
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Brian Schwartz (18 shared papers)Kyriakos P. Papadopoulos (8 shared papers)Walid L. Shaib (6 shared papers)Giovanni Abbadessa (10 shared papers)Vincenzo Mazzaferro (4 shared papers)Bassel F. El‐Rayes (5 shared papers)Christian Cotsoglou (3 shared papers)Nevena Damjanov (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)British Journal of Cancer (2 papers)Molecular Case Studies (1 paper)
- Partner nations
- United StatesItalySwitzerland
In The Last Decade
Julia Kazakin
24 papers receiving 580 citations
Julia Kazakin's Hit Papers
Peers
Comparison fields: 5 of 41
- Surgery 365
- Oncology 223
- Hepatology 48
- Pulmonary and Respiratory Medicine 104
- Pathology and Forensic Medicine 57
Countries citing papers authored by Julia Kazakin
This map shows the geographic impact of Julia Kazakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Kazakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Kazakin more than expected).
Fields of papers citing papers by Julia Kazakin
This network shows the impact of papers produced by Julia Kazakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Kazakin. The network helps show where Julia Kazakin may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Kazakin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma Hit paper breakdown → | 2018 | 268 |
| 2 | 2017 | 79 | |
| 3 | 2014 | 73 | |
| 4 | 2019 | 34 | |
| 5 | 2020 | 28 | |
| 6 | 2017 | 23 | |
| 7 | 2011 | 13 | |
| 8 | 2018 | 10 | |
| 9 | 2016 | 9 | |
| 10 | 2015 | 8 | |
| 11 | 2010 | 6 | |
| 12 | 2004 | 5 | |
| 13 | Preliminary Dosimetry Results from a First-in-Human Phase I Study Evaluating the Efficacy and Safety of [225Ac]-FPI-1434 in Patients with IGF-1R Expressing Solid Tumors | 2021 | 5 |
| 14 | 2019 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 2011 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2004 | 2 | |
| 20 | 2002 | 2 |
About Julia Kazakin
Julia Kazakin is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 24 papers that have together received 588 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Head and Neck Cancer Studies (2 papers), Cancer Diagnosis and Treatment (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Surgery (365 citations), Oncology (223 citations), Hepatology (48 citations), Pulmonary and Respiratory Medicine (104 citations) and Pathology and Forensic Medicine (57 citations). Julia Kazakin has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Brian Schwartz, Kyriakos P. Papadopoulos, Walid L. Shaib, Giovanni Abbadessa, Vincenzo Mazzaferro, Bassel F. El‐Rayes, Christian Cotsoglou, Nevena Damjanov, William Proctor Harris and Nicola Personeni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Cancer and Molecular Case Studies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.